{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:23:53Z","timestamp":1778711033414,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>The multistep process of oral carcinogenesis provides a biological rationale for the use of chemoprevention in individuals at increased risk of developing oral cancer. We aimed to determine if low doses of propranolol can prevent the development of oral cancer using a tobacco-relevant and p53-associated animal model of cancer initiation. Twenty-six Wistar rats were randomly allocated into two groups, vehicle, and propranolol. All animals received 4-nitroquinoline N-oxide (4NQO) at 25\u2009ppm diluted in the drinking water for 20\u2009weeks. Animals from the propranolol group received propranolol (0.1\u2009mg\/kg) 5\u2009days per week by gavage for 18\u2009weeks. The clinical analysis was performed by measuring the area of the lesion and assessment of scores based on lesion appearance (papule; plaque; nodule or ulcerated). Histopathological analysis was performed to determine the presence of epithelial dysplasia or invasive squamous cell carcinoma (SCC). The average lesion area in 4NQO\u2009+\u2009vehicle and in 4NQO\u2009+\u2009propranolol groups were 0.20\u2009 and 0.28\u2009mm<jats:sup>2<\/jats:sup>, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.53). The percentage of cases clinically graded as papules, thick plaques, nodular areas, and ulcerated lesions was similar between groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.94). Histopathological diagnosis also did not differ between groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.65), with 54.5 and 70% of cases being diagnosed as SCC in 4NQO and in 4NQO\u2009+\u2009propranolol groups, respectively. In conclusion, daily doses propranolol at 0.1\u2009mg\/kg were not as effective as a chemopreventive therapy in an animal model of 4NQO-induced carcinogenesis.<\/jats:p>","DOI":"10.1097\/cej.0000000000000626","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T03:00:41Z","timestamp":1604286041000},"page":"315-321","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Can propranolol act as a chemopreventive agent during oral carcinogenesis? An experimental animal study"],"prefix":"10.1097","volume":"30","author":[{"given":"Vivian P.","family":"Wagner","sequence":"first","affiliation":[{"name":"Department of Oral Pathology, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul"},{"name":"Department of Oral Diagnosis, University of Campinas, Piracicaba, S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias R.","family":"Spuldaro","sequence":"additional","affiliation":[{"name":"Department of Periodontology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"N\u00f6r","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul"},{"name":"Department of Oral Pathology, Radiology and Medicine, University of Iowa College of Dentistry, Iowa City, Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo J.","family":"Gaio","sequence":"additional","affiliation":[{"name":"Department of Periodontology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogerio M.","family":"Castilho","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Oral Medicine, Laboratory of Epithelial Biology, University of Michigan School of Dentistry; Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius C.","family":"Carrard","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassiano K.","family":"R\u00f6sing","sequence":"additional","affiliation":[{"name":"Department of Periodontology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbi.2010.12.012","article-title":"Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells.","volume":"25","author":"Bernab\u00e9","year":"2011","journal-title":"Brain Behav Immun"},{"key":"R2-20250527","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9090113","article-title":"Novel molecular targets for chemoprevention in malignancies of the head and neck.","volume":"9","author":"Bhatia","year":"2017","journal-title":"Cancers (Basel)"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/odi.12095","article-title":"Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.","volume":"20","author":"Brouns","year":"2014","journal-title":"Oral Dis"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10735-011-9388-5","article-title":"Alkylation-induced genotoxicity as a predictor of DNA repair deficiency following experimental oral carcinogenesis.","volume":"43","author":"Carvalho","year":"2012","journal-title":"J Mol Histol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1097\/MD.0000000000001097","article-title":"Propranolol reduces cancer risk: a population-based cohort study.","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/ncponc1134","article-title":"Do stress-related psychosocial factors contribute to cancer incidence and survival?.","volume":"5","author":"Chida","year":"2008","journal-title":"Nature clinical practice. Oncology"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","article-title":"Molecular pathways: beta-adrenergic signaling in cancer.","volume":"18","author":"Cole","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/1940-6207.CAPR-08-0147","article-title":"Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model.","volume":"2","author":"Czerninski","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0964-1955(96)00048-6","article-title":"Experimental tongue cancer in desalivated rats.","volume":"33","author":"Dayan","year":"1997","journal-title":"Oral Oncol"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tox.2006.11.045","article-title":"4-NQO induces apoptosis via p53-dependent mitochondrial signaling pathway.","volume":"230","author":"Han","year":"2007","journal-title":"Toxicology"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1940-6207.CAPR-08-0211","article-title":"ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.","volume":"2","author":"Hasina","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.07.028","article-title":"Current mouse models of oral squamous cell carcinoma: genetic and chemically induced models.","volume":"73","author":"Ishida","year":"2017","journal-title":"Oral Oncol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jgm.1473","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines.","volume":"12","author":"Kilkenny","year":"2010","journal-title":"J Gene Med"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2203\/dose-response.13-051.Lushchak","article-title":"Dissection of the hormetic curve: analysis of components and mechanisms.","volume":"12","author":"Lushchak","year":"2014","journal-title":"Dose Response"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.archoralbio.2018.02.001","article-title":"Spontaneous alveolar bone loss after 4NQO exposure in Wistar rats.","volume":"89","author":"Oballe","year":"2018","journal-title":"Arch Oral Biol"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.21723","article-title":"The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB\/c nude mice is inhibited by beta-blockers.","volume":"118","author":"Palm","year":"2006","journal-title":"Int J Cancer"},{"key":"R17-20250527","first-page":"680","article-title":"Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.","volume":"10","author":"Pantziarka","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3332\/ecancer.2018.886","article-title":"ReDO_DB: the repurposing drugs in oncology database.","volume":"12","author":"Pantziarka","year":"2018","journal-title":"Ecancermedicalscience"},{"key":"R19-20250527","first-page":"937","article-title":"Imbalance of tumor suppression genes expression following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.","volume":"23","author":"Ribeiro","year":"2009","journal-title":"In Vivo"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-0039-1698331","article-title":"Gingival changes in Wistar rats after oral treatment with 4-nitroquinoline 1-oxide.","volume":"1","author":"Ribeiro","year":"2007","journal-title":"Eur J Dent"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1476-5381.2011.01686.x","article-title":"Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.","volume":"165","author":"Rodrigues","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0714.2008.00691.x","article-title":"Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.","volume":"38","author":"Shang","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.oraloncology.2015.02.101","article-title":"Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions.","volume":"51","author":"Sheth","year":"2015","journal-title":"Oral Oncol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","article-title":"The sympathetic nervous system induces a metastatic switch in primary breast cancer.","volume":"70","author":"Sloan","year":"2010","journal-title":"Cancer Res"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma.","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1078-0432.CCR-0999-3","article-title":"Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.","volume":"10","author":"Tang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/odi.12342","article-title":"The INHANCE consortium: toward a better understanding of the causes and mechanisms of head and neck cancer.","volume":"21","author":"Winn","year":"2015","journal-title":"Oral Dis"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40273-014-0169-3","article-title":"The economic burden of head and neck cancer: a systematic literature review.","volume":"32","author":"Wissinger","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"R30-20250527","first-page":"334","article-title":"Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma.","volume":"41","author":"Wolter","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:02:28Z","timestamp":1748361748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000626","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,29]]}}}